Annual SGA
$19.00 M
+$1.75 M+10.13%
December 31, 2023
Summary
- As of February 7, 2025, ABEO annual SGA is $19.00 million, with the most recent change of +$1.75 million (+10.13%) on December 31, 2023.
- During the last 3 years, ABEO annual SGA has fallen by -$4.78 million (-20.08%).
- ABEO annual SGA is now -20.08% below its all-time high of $23.78 million, reached on December 31, 2020.
Performance
ABEO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.40 M
-$2.24 M-25.93%
September 30, 2024
Summary
- As of February 7, 2025, ABEO quarterly SGA is $6.40 million, with the most recent change of -$2.24 million (-25.93%) on September 30, 2024.
- Over the past year, ABEO quarterly SGA has increased by +$574.00 thousand (+9.85%).
- ABEO quarterly SGA is now -25.93% below its all-time high of $8.65 million, reached on June 30, 2024.
Performance
ABEO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.11 B
-$71.03 M-2.34%
September 30, 2024
Summary
- As of February 7, 2025, ABEO TTM SGA is -$3.11 billion, with the most recent change of -$71.03 million (-2.34%) on September 30, 2024.
- Over the past year, ABEO TTM SGA has dropped by -$3.13 billion (-16455.96%).
- ABEO TTM SGA is now -12905.38% below its all-time high of -$23.90 million.
Performance
ABEO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ABEO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | +9.8% | -10000.0% |
| 3 y3 years | -20.1% | +10.1% | -10000.0% |
| 5 y5 years | -5.5% | +36.3% | -10000.0% |
ABEO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.2% | +10.1% | -25.9% | +85.1% | -26.7% | at low |
| 5 y | 5-year | -20.1% | +10.1% | -25.9% | +85.1% | -69.1% | at low |
| alltime | all time | -20.1% | +1306.7% | -25.9% | +2034.7% | <-9999.0% | at low |
Abeona Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.40 M(-25.9%) | $28.00 M(+8.7%) |
| Jun 2024 | - | $8.65 M(+21.4%) | $25.75 M(+16.4%) |
| Mar 2024 | - | $7.12 M(+22.2%) | $22.13 M(+16.4%) |
| Dec 2023 | $19.00 M(+10.1%) | $5.83 M(+40.3%) | $19.00 M(+0.8%) |
| Sep 2023 | - | $4.16 M(-17.2%) | $18.86 M(+1.4%) |
| Jun 2023 | - | $5.02 M(+25.6%) | $18.59 M(+9.2%) |
| Mar 2023 | - | $4.00 M(-29.7%) | $17.03 M(-1.3%) |
| Dec 2022 | $17.26 M(-20.3%) | $5.68 M(+46.1%) | $17.26 M(+8.1%) |
| Sep 2022 | - | $3.89 M(+12.4%) | $15.96 M(-10.8%) |
| Jun 2022 | - | $3.46 M(-18.1%) | $17.88 M(-8.8%) |
| Mar 2022 | - | $4.22 M(-3.6%) | $19.61 M(-9.5%) |
| Dec 2021 | $21.64 M(-9.0%) | $4.38 M(-24.6%) | $21.66 M(-12.2%) |
| Sep 2021 | - | $5.82 M(+12.2%) | $24.68 M(+5.9%) |
| Jun 2021 | - | $5.18 M(-17.5%) | $23.29 M(-1.5%) |
| Mar 2021 | - | $6.28 M(-15.1%) | $23.65 M(-0.6%) |
| Dec 2020 | $23.78 M(+14.8%) | $7.40 M(+66.9%) | $23.78 M(+12.6%) |
| Sep 2020 | - | $4.43 M(-20.0%) | $21.12 M(-1.3%) |
| Jun 2020 | - | $5.54 M(-13.6%) | $21.38 M(-0.3%) |
| Mar 2020 | - | $6.41 M(+35.4%) | $21.46 M(+3.6%) |
| Dec 2019 | $20.70 M(+3.0%) | $4.73 M(+0.7%) | $20.70 M(-12.3%) |
| Sep 2019 | - | $4.70 M(-16.3%) | $23.60 M(-1.1%) |
| Jun 2019 | - | $5.61 M(-0.8%) | $23.87 M(+4.3%) |
| Mar 2019 | - | $5.66 M(-25.8%) | $22.89 M(+13.8%) |
| Dec 2018 | $20.11 M(+83.7%) | $7.63 M(+53.5%) | $20.11 M(+29.0%) |
| Sep 2018 | - | $4.97 M(+7.4%) | $15.59 M(+21.9%) |
| Jun 2018 | - | $4.63 M(+60.8%) | $12.78 M(+18.4%) |
| Mar 2018 | - | $2.88 M(-7.5%) | $10.80 M(-1.3%) |
| Dec 2017 | $10.94 M(-17.7%) | $3.11 M(+43.7%) | $10.94 M(+2.9%) |
| Sep 2017 | - | $2.17 M(-18.0%) | $10.63 M(-2.1%) |
| Jun 2017 | - | $2.64 M(-12.6%) | $10.86 M(-9.1%) |
| Mar 2017 | - | $3.02 M(+7.8%) | $11.95 M(-10.1%) |
| Dec 2016 | $13.29 M(-7.2%) | $2.80 M(+17.2%) | $13.29 M(-9.8%) |
| Sep 2016 | - | $2.39 M(-35.9%) | $14.73 M(-13.6%) |
| Jun 2016 | - | $3.73 M(-14.6%) | $17.06 M(+0.4%) |
| Mar 2016 | - | $4.37 M(+2.8%) | $17.00 M(+18.7%) |
| Dec 2015 | $14.32 M(+285.8%) | $4.25 M(-10.0%) | $14.32 M(+33.5%) |
| Sep 2015 | - | $4.72 M(+28.6%) | $10.73 M(+57.6%) |
| Jun 2015 | - | $3.67 M(+117.1%) | $6.81 M(+69.8%) |
| Mar 2015 | - | $1.69 M(+157.1%) | $4.01 M(+8.0%) |
| Dec 2014 | $3.71 M(-23.2%) | $657.00 K(-17.4%) | $3.71 M(-1.6%) |
| Sep 2014 | - | $795.00 K(-8.4%) | $3.77 M(+4.2%) |
| Jun 2014 | - | $868.00 K(-37.6%) | $3.62 M(-26.0%) |
| Mar 2014 | - | $1.39 M(+94.1%) | $4.89 M(+1.1%) |
| Dec 2013 | $4.83 M(-19.8%) | $717.00 K(+11.7%) | $4.83 M(-14.4%) |
| Sep 2013 | - | $642.00 K(-70.0%) | $5.65 M(-12.1%) |
| Jun 2013 | - | $2.14 M(+59.7%) | $6.43 M(+12.8%) |
| Mar 2013 | - | $1.34 M(-12.7%) | $5.70 M(-5.4%) |
| Dec 2012 | $6.02 M(+4.7%) | $1.53 M(+7.8%) | $6.02 M(+3.4%) |
| Sep 2012 | - | $1.42 M(+1.1%) | $5.82 M(-6.1%) |
| Jun 2012 | - | $1.41 M(-15.5%) | $6.20 M(+0.0%) |
| Mar 2012 | - | $1.66 M(+24.8%) | $6.20 M(+11.4%) |
| Dec 2011 | $5.75 M | $1.33 M(-26.0%) | $5.57 M(+2.5%) |
| Sep 2011 | - | $1.80 M(+28.3%) | $5.43 M(+13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $1.40 M(+36.8%) | $4.79 M(+3.3%) |
| Mar 2011 | - | $1.03 M(-14.1%) | $4.64 M(+2.8%) |
| Dec 2010 | $4.51 M(-36.6%) | $1.20 M(+2.6%) | $4.51 M(+7.0%) |
| Sep 2010 | - | $1.17 M(-7.0%) | $4.22 M(-35.2%) |
| Jun 2010 | - | $1.25 M(+39.5%) | $6.51 M(-3.8%) |
| Mar 2010 | - | $898.00 K(-0.2%) | $6.76 M(-4.9%) |
| Dec 2009 | $7.11 M(-4.7%) | $900.00 K(-74.0%) | $7.11 M(-3.8%) |
| Sep 2009 | - | $3.46 M(+129.5%) | $7.39 M(+21.2%) |
| Jun 2009 | - | $1.51 M(+20.9%) | $6.10 M(+8.2%) |
| Mar 2009 | - | $1.25 M(+5.9%) | $5.64 M(+6.8%) |
| Dec 2008 | $7.46 M(+83.1%) | $1.18 M(-45.6%) | $5.28 M(+7.2%) |
| Sep 2008 | - | $2.17 M(+107.6%) | $4.92 M(+31.1%) |
| Jun 2008 | - | $1.04 M(+17.4%) | $3.76 M(-1.8%) |
| Mar 2008 | - | $889.00 K(+7.9%) | $3.83 M(-6.1%) |
| Dec 2007 | $4.08 M(+44.9%) | $824.00 K(-17.6%) | $4.08 M(+3.6%) |
| Sep 2007 | - | $1.00 M(-10.2%) | $3.94 M(+5.4%) |
| Jun 2007 | - | $1.11 M(-2.3%) | $3.74 M(+13.7%) |
| Mar 2007 | - | $1.14 M(+66.5%) | $3.29 M(+16.8%) |
| Dec 2006 | $2.81 M(-39.3%) | $684.00 K(-14.5%) | $2.81 M(-21.2%) |
| Sep 2006 | - | $800.00 K(+20.7%) | $3.57 M(+3.1%) |
| Jun 2006 | - | $663.00 K(-0.5%) | $3.46 M(-25.0%) |
| Mar 2006 | - | $666.00 K(-53.8%) | $4.62 M(-0.5%) |
| Dec 2005 | $4.64 M(+45.0%) | $1.44 M(+107.8%) | $4.64 M(+13.9%) |
| Sep 2005 | - | $693.00 K(-61.8%) | $4.07 M(-2.5%) |
| Jun 2005 | - | $1.82 M(+163.6%) | $4.18 M(+33.3%) |
| Mar 2005 | - | $689.00 K(-21.2%) | $3.13 M(-2.0%) |
| Dec 2004 | $3.20 M(+27.2%) | $874.00 K(+9.4%) | $3.20 M(+1.2%) |
| Sep 2004 | - | $799.00 K(+3.5%) | $3.16 M(+10.0%) |
| Jun 2004 | - | $772.00 K(+2.4%) | $2.87 M(+5.2%) |
| Mar 2004 | - | $754.00 K(-9.7%) | $2.73 M(+8.6%) |
| Dec 2003 | $2.51 M(+10.4%) | $835.00 K(+63.1%) | $2.51 M(+3.2%) |
| Sep 2003 | - | $512.00 K(-18.7%) | $2.44 M(+2.7%) |
| Jun 2003 | - | $630.00 K(+17.3%) | $2.37 M(+2.5%) |
| Mar 2003 | - | $537.00 K(-29.2%) | $2.31 M(+1.7%) |
| Dec 2002 | $2.28 M(+16.2%) | $758.00 K(+68.8%) | $2.28 M(+7.3%) |
| Sep 2002 | - | $449.00 K(-21.4%) | $2.12 M(-0.4%) |
| Jun 2002 | - | $571.00 K(+14.4%) | $2.13 M(+5.3%) |
| Mar 2002 | - | $499.00 K(-17.2%) | $2.02 M(+3.2%) |
| Dec 2001 | $1.96 M(+12.8%) | $603.00 K(+31.9%) | $1.96 M(+3.8%) |
| Sep 2001 | - | $457.00 K(-1.3%) | $1.89 M(+7.1%) |
| Jun 2001 | - | $463.00 K(+6.2%) | $1.76 M(-1.3%) |
| Mar 2001 | - | $436.00 K(-17.9%) | $1.79 M(+2.9%) |
| Dec 2000 | $1.74 M(+15.7%) | $531.00 K(+59.9%) | $1.74 M(+15.3%) |
| Sep 2000 | - | $332.00 K(-31.8%) | $1.50 M(+2.2%) |
| Jun 2000 | - | $487.00 K(+26.2%) | $1.47 M(-0.9%) |
| Mar 2000 | - | $386.00 K(+28.7%) | $1.49 M(-0.9%) |
| Dec 1999 | $1.50 M(0.0%) | $300.00 K(0.0%) | $1.50 M(+25.0%) |
| Sep 1999 | - | $300.00 K(-40.0%) | $1.20 M(+33.3%) |
| Jun 1999 | - | $500.00 K(+25.0%) | $900.00 K(+125.0%) |
| Mar 1999 | - | $400.00 K | $400.00 K |
| Dec 1998 | $1.50 M(-15.9%) | - | - |
| Dec 1997 | $1.78 M(-7.9%) | - | - |
| Dec 1996 | $1.94 M(+43.4%) | - | - |
| Dec 1995 | $1.35 M | - | - |
FAQ
- What is Abeona Therapeutics annual SGA?
- What is the all time high annual SGA for Abeona Therapeutics?
- What is Abeona Therapeutics annual SGA year-on-year change?
- What is Abeona Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly SGA year-on-year change?
- What is Abeona Therapeutics TTM SGA?
- What is the all time high TTM SGA for Abeona Therapeutics?
- What is Abeona Therapeutics TTM SGA year-on-year change?
What is Abeona Therapeutics annual SGA?
The current annual SGA of ABEO is $19.00 M
What is the all time high annual SGA for Abeona Therapeutics?
Abeona Therapeutics all-time high annual SGA is $23.78 M
What is Abeona Therapeutics annual SGA year-on-year change?
Over the past year, ABEO annual SGA has changed by +$1.75 M (+10.13%)
What is Abeona Therapeutics quarterly SGA?
The current quarterly SGA of ABEO is $6.40 M
What is the all time high quarterly SGA for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly SGA is $8.65 M
What is Abeona Therapeutics quarterly SGA year-on-year change?
Over the past year, ABEO quarterly SGA has changed by +$574.00 K (+9.85%)
What is Abeona Therapeutics TTM SGA?
The current TTM SGA of ABEO is -$3.11 B
What is the all time high TTM SGA for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM SGA is -$23.90 M
What is Abeona Therapeutics TTM SGA year-on-year change?
Over the past year, ABEO TTM SGA has changed by -$3.13 B (-16455.96%)